Assignee
GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD
CN·4 granted patents·10 pending applications·4 citations·filing 2018–2024
Top patents by PatentIndex Score
14 records- 0190US11840575B2Engineered immune cells targeting BCMA and their uses thereofGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2020·Granted Dec 12, 2023·4 cites·28 claims
- 0271US2024335474A1Compositions and methods for immunotherapyGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2024·Application pending·0 cites
- 0370US12540191B2Engineered immune cells targeting BCMA and their uses thereofGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2023·Granted Feb 3, 2026·0 cites·32 claims
- 0466US12454564B2Compositions and methods for T cell engineeringGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2022·Granted Oct 28, 2025·0 cites·11 claims
- 0565US2025064855A1Use of dual-target CAR-T cells in treating B-cell autoimmune diseasesGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2024·Application pending·0 cites
- 0662US2023381233A1Compositions and methods for t cell engineeringGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0760US2025163475A1Systems and methods for cell modificationGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0859US2021369779A1Compositions and methods for immunotherapyGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0958US2021332101A1Compositions and methods for t cell engineeringGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1055US2024408199A1Chimeric antigen receptor immune cell, and preparation method therefor and application thereofGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1149US2023235052A1Humanized cd19 antibody and use thereofGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1248US2023113157A1Compositions and methods for t cell engineeringGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
- 1347US12049487B2Universal chimeric antigen receptor T-cell preparation techniqueGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2018·Granted Jul 30, 2024·0 cites·10 claims
- 1445US2020255803A1Engineered immune cell capable of inducing secretion of anti-cd47 antibodyGRACELL BIOTECHNOLOGIES (SHANGHAI) CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →